Brain diseases collectively represent one of the largest areas of unmet medical need, affecting upwards of 1.5 billion patients globally. Neumora was founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our goal is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients.

We’ve built a pipeline comprised of programs for neuropsychiatric disorders and neurodegenerative diseases, each targeting a novel mechanism of action where we can leverage our precision neuroscience approach. Our pipeline currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. 

Neumora is committed to addressing some of the most prevalent brain health disorders and transforming the standard of care for millions of patients living with brain diseases. Learn more about Neumora and career opportunities on our website below.

Mubadala Capital Ventures

Invus

Abu Dhabi Growth Fund

Altitude Life Science Ventures

Amgen

EXOR N.V.

ARCH Venture Partners

Newpath Management

Polaris Partners

F-Prime Capital

Neumora

We are delighted to welcome Kaya Pai Panandiker as Chief Commercial Officer. Kaya brings to Neumora extensive commercial strategy and execution expertise, having led the launches of multiple neuropsychiatry products throughout her career. Read more: https://lnkd.in/ex-Zr2JP

Each year, our CEO Excellence Awards celebrate individuals or cross functional teams who demonstrate our values every day by achieving the extraordinary, creating value and doing what is right. We were thrilled to recognize our 2023 winners, Karla Zeitz, Jason Morton, Partha Mudipalli, Ph.D., Hong Ji, Santnu P., Michael Eyre, Heather Stemper, Palwasha T., Leanna Bui, Tash Barrow, Kelly Voong and Anh Le Vynh, for their outstanding contributions to Neumora. Thank you for your unwavering dedication to this work!

We’ve had a great week connecting with #JPM24 attendees! #ICYMI, check out CEO Henry Gosebruch’s podium presentation, outlining the exciting year ahead and our industry-leading pipeline. We look forward to continuing to pioneer a new era in brain disease and lead innovation in brain health throughout 2024. https://lnkd.in/eRFzBnEY

Neumora was founded to improve the lives of people living with brain diseases. To do that, we’ve built an industry-leading pipeline comprised of programs for neuropsychiatric disorders and neurodegenerative diseases, each targeting a novel mechanism of action. Learn more about our pipeline below. #JPM24

We are heading to San Francisco next week for #JPM24! CEO Henry Gosebruch will present on Monday, January 8 at 11:15AM PT. Learn more below. https://lnkd.in/ePiU73Zx

We are headed into this holiday season filled with gratitude for those around us. Wishing you the happiest of holidays from all of us at Neumora!

A recent NAMI study found that 64% of people with a mental illness said holidays make their conditions worse. It's important to put yourself first and prioritize your well-being, especially during the holiday season. We're sharing some of our favorite tips from NAMI and The Jed Foundation (JED) on how to reduce stress and maintain good #mentalhealth in the coming weeks. In an emergency, dial 988 to reach the suicide and crisis lifeline.

We are pleased to welcome Jason G. Duncan to Neumora as Chief Legal Officer. Jason's decades of legal, compliance, development and operations experience will be invaluable to our team as we continue to progress our pipeline. Read more: https://lnkd.in/eUdk_Gkr

We had a great time in Tampa at #ACNP2023, where Dr. Sanjay Mathew presented data from our #MDD program. It was great to connect with so many neuropsych thought leaders!

Today we announced IND clearance and the initiation of a Phase 1 study for NMRA-266, our M4 positive allosteric modulator. Read more here. https://lnkd.in/e_Vz_cjb

Monument Therapeutics is a biotechnology company with a focus on neuroscience and psychiatry. The company develops treatments for serious diseases of the central nervous system using a precision medicine approach, which involves the use of proprietary digital biomarkers to identify patients with specific neurobiological characteristics and match them with targeted compounds.

Monument Therapeutics

Neumora Therapeutics operates as a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience.

Neumora Therapeutics

Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company's pipeline includes novel treatments targeting various CNS diseases with a precision medicine approach.

Senior Director, Electrophysiology

Director

Director, Electrophysiology

Research Assistant Professor

Program Director

Research Scientist

Graduate Student

Senior Director

Tarek Deeb

Director, Toxicology

Principal Scientist

Senior Research Operations Manager

Research Operations Manager

Consultant

Senior Scientist

Scientist

Karla Zeitz

Director, Clinical Operation Program Excellence

Director Clinical Operations

Director of Clinical Operations

Clinical Project Lead/Clinical Trial Manager

Clinical Project Manager

Clinical Project Lead, Clinical Operations

Clinical  Research Program Coordinator

Lead Project Manager

Study Coordinator – Data Management

Director, Clinical Operations Program Excellence

Adriana Manari

Director, Program Management

Director, Program Management/ Asset Operational Lead

Sage Therapeutics

Director, Alliance Management

Associate Director, Alliance Management

Associate Director, Program Management

Takeda Oncology

Global Launch Project Manager

Manager, Marketing Effectiveness

Project Coordinator, New Product Specialist

Experienced Biotech Project, Program, and Alliance Manager

Kate Carioli

Director of Biostatistics

Associate Director Biostatistics

Associate Director of Biostatistics

Principal Biostatistician

Sr. Biostatistician II

Biostatistician

postdoctoral associate

Director of Biostatistics at Neumora Therapeutics

Xueping Zhang

Senior Research Associate

Research Associate II

Intern

Director, Discovery Chemistry

Anne-Marie Beausoleil

Chief Legal Officer

Chief Legal Officer | General Counsel & Secretary | Head of Program Management

General Counsel and Secretary

General Counsel, Americas

Vice President, Head of Compliance and Legal, North America

Associate General Counsel, Neurology and Discovery

Senior Therapeutic Area Counsel, Neurology

Therapeutic Area Counsel, Neurology

Associate, Business Group

Associate, Corporate and Financial Markets Groups

Life Sciences Executive | Enterprise Leader | Chief Legal Officer

Jason Duncan

Director, Quality Control

Associate Director

Lab Manager

Director, Quality Control at Neumora

Heather Stemper

Head of Analytical Development and Quality Control

Director, Analytical development and quality control

Hong Ji

Chief Human Resources Officer

SVP, Head of Human Resources

VP, Talent

Head of Human Resources (Interim)

Director, Human Resource Business Partner

Global Head of Talent Management & Leadership Development (Shire)

Global Head Of Talent Management & Leadership Development

Director and Lead HR Business Partner

Associate Director, Senior Human Resources Business Partner

Human Resource Generalist

Recruiting Coordinator

Amy Sullivan

Senior Director, Manufacturing Operations

Director, CMC Development

Director, Technical Operations

Director, Process Engineering and Operations, Chemical Process Research & Development

Associate Director, Global Branded Products CMC

Associate Director, Technical Operations

Senior Director, Technical Operations

Partha Mudipalli

Regulatory Toxicology Consultant

Principal Investigator

Manager, Toxicology Department

Scientist II - Global Exploratory Development - Drug Safety Evaluation

Senior Research Scientist II - Study Director

Graduate Fellow

Director, Toxicology at Verve Therapeutics, Inc.

Joel Cooper

Head of Data Engineering

Director of Data Engineering

Senior Manager

VP Principal Architect

Senior Lead Developer and Cloud Infrastructure Architect

Senior Technical Manager

Senior Software Developer

Senior Software Engineer

Sr. Software Developer

Software Developer

Head of Data Engineering at Neumora

Sathish Koduru

Associate Director, Clinical Scientist

Clinical Scientist

Senior Clinical Trial Manager

Clinical Sleep Scientist

Clinical Research Scientist

Research Affiliate

Postdoctoral Research Fellow in Dr. Edythe London's Laboratory of Molecular Neuroimaging

Predoctoral Research Fellow in Dr. Harriet de Wit's Human Behavioral Pharmacology Laboratory

Associate Pharmacologist in Behavioral Neuroscience

Assistant Pharmacologist in Behavioral Neuroscience

Research Assistant in the laboratory of Dr. Stephen Holtzman

Michael Ballard

Director, Quality Document Control & Training

Associate Director, Global Documents & Records Management

Senior Manager, Quality Assurance

Senior Quality Assurance & Document Control Specialist

Supervisor, Corporate Services Compliance

PM / Cal Administrator II

Administrative Assistant

Portfolio Account Administrator

Debbie Chan

Independent Contractor

Sr. Clinical Trial Manager- Contractor

Sr. Country Study Manager- Contractor

Sr. Clinical Trial Manager

Director Clinical Operations, Neumora Therapeutics

Eugene Vass

Prajwal Vikram

Human Resources Director

Associate Director, Total Rewards

Senior HR Manager

HR Professional

Talent Programs Analyst

HR Analyst

Director, HR at Neumora Therapeutics

Linda Peterson

Senior Executive Administrator to Co-founders, CEO and G&A Executive Team

Founder | Owner

Senior Executive Assistant to the CEO, CFO and Investor Relations

Executive Assistant to the CEO, CFO and VP of Investor Relations

Executive Assistant to the CFO and VP of Investor Relations

Executive Assistant to VP of Network Development (Consultant)

Executive Assistant to President and CEO (Consultant)

Senior Executive Administrator | Workplace Wellness Specialist | Certified Wellness Practitioner

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general	Mar 5, 2024 2:37 AM	304af5ea
public peers	general
news daily refresh	general	Sep 3, 2024 1:30 PM	a0ade48e
news processing daily refresh	general	Sep 3, 2024 2:50 PM	eb5cdb40
news impact assignment daily	general	Sep 2, 2024 11:37 PM	03162d9c
news processing basic	general	Mar 5, 2024 2:37 AM	8bb3beaa
company summary	general	Aug 30, 2024 6:31 PM	b5be7711
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Mar 5, 2024 2:37 AM	b14c2ef0
translate crunchbase fundingrounds	general
peers	general
news basic	general	Mar 5, 2024 2:37 AM	d23df3c2
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
company structure	company_analysis
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

COM:NEUMORATX

Neumora Therapeutics, Inc.

Last Close

13.02

08/11 21:00

Market Cap

1.72B

Beta: -

Volume Today

1.14M

Avg: -